All type of patients: 26 trials - CTONG0806 (Yang) - NCIC CTG BR19 (Goss) - NEJ002 - INFORM; C-TONG 0804 - EORTC 08021/ILCP 01/03 - IFCT-0301 study (Morère) - ISTANA (Lee) - Maemondo - WJTOG0203 (Takeda) - WJTOG3405 (Mitsudomi) - Goss - IPASS (Mok) - INTEREST (Kim) - INVITE (Crinò) - SWOG S0023 (Kelly) - V-15-32 (Maruyama) - ISEL - SIGN (Cufer) - Tsuboi - INTACT 2 - Kris - First Signal - INTACT 1. - IPASS - Northeast Japan - West Japan
First line: 7 trials - NEJ002 - IPASS (Mok) - INVITE (Crinò) - INTACT 2 - First Signal - INTACT 1. - IPASS
Second line: 8 trials - EORTC 08021/ILCP 01/03 - ISTANA (Lee) - Maemondo - INTEREST (Kim) - V-15-32 (Maruyama) - ISEL - SIGN (Cufer) - Kris
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
